News
The global burden of atopic dermatitis in adults aged 60 and older has risen from 1990 to 2021, mainly due to population growth, with higher incidence in women and those aged 75–79 years.
Atopic dermatitis, the most common form of eczema, affects millions of Americans with its hallmark symptoms of dry, itchy, and inflamed skin. While this chronic condition can impact individuals ...
Bosakitug is under clinical development by Biosion and currently in Phase II for Atopic Dermatitis (Atopic Eczema ... The therapeutic candidate was under development for the treatment of cat allergy.
This accomplishment underscores the drug's effectiveness across various indications, particularly in atopic dermatitis (AD), where it is widely regarded as the gold standard (1 Trusted ...
Diagnosing and managing feline atopic dermatitis (FAD) can be difficult for clients, and can even be a challenge for veterinary professionals can diagnose due to the complexities the causes can create ...
The American Academy of Dermatology gratefully acknowledges the support from Sanofi and Regeneron. Atopic dermatitis, or eczema, is often called the “itch that rashes.” This description explains what ...
I was diagnosed with atopic dermatitis when I was 2 years old ... It's very clear from those pictures just how much the condition truly affected me. I remember sleeping with my parents to try ...
The point prevalence of atopic dermatitis was highest in those aged 0 to 5 years among children and adolescents and in those aged 18 to 59 years among adults. The estimated global point prevalence ...
THE constitutional character of atopic dermatitis is generally recognized ... which would then produce clinical pictures and laboratory findings similar to those present in Case 1 of this series.
Nemolizumab, an interleukin 31 receptor antagonist, was well tolerated and significantly improved inflammation and pruritus in patients with moderate to severe atopic dermatitis (AD). "Nemolizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results